Epilepsia, ISSN 0013-9580, 07/2013, Volume 54, Issue 7, pp. 1282 - 1287
Summary Purpose KCNQ2 mutations have been found in patients with benign familial neonatal seizures, myokymia, or early onset epileptic encephalopathy (EOEE)....
Ohtahara syndrome | Early onset epileptic encephalopathy | Ion channel | Mosaic | KCNQ2 | MENTAL-RETARDATION | CLINICAL NEUROLOGY | FAMILIAL NEONATAL CONVULSIONS | MYOCLONIC EPILEPSY | SEIZURES | DE-NOVO MUTATIONS | BENIGN | EXPANSION | SEQUENCING DATA | CHANNEL GENE | OHTAHARA-SYNDROME | Genetic Predisposition to Disease - genetics | Genetic Testing | Humans | Exons - genetics | Infant | Male | Tomography, X-Ray Computed | Electroencephalography | Epilepsy - physiopathology | Mutation - genetics | Magnetic Resonance Imaging | DNA Mutational Analysis | KCNQ2 Potassium Channel - genetics | Epilepsy - genetics | Female | Infant, Newborn | Anticonvulsants | Genetic aspects | Seizures (Medicine) | Invisibility | EEG
Ohtahara syndrome | Early onset epileptic encephalopathy | Ion channel | Mosaic | KCNQ2 | MENTAL-RETARDATION | CLINICAL NEUROLOGY | FAMILIAL NEONATAL CONVULSIONS | MYOCLONIC EPILEPSY | SEIZURES | DE-NOVO MUTATIONS | BENIGN | EXPANSION | SEQUENCING DATA | CHANNEL GENE | OHTAHARA-SYNDROME | Genetic Predisposition to Disease - genetics | Genetic Testing | Humans | Exons - genetics | Infant | Male | Tomography, X-Ray Computed | Electroencephalography | Epilepsy - physiopathology | Mutation - genetics | Magnetic Resonance Imaging | DNA Mutational Analysis | KCNQ2 Potassium Channel - genetics | Epilepsy - genetics | Female | Infant, Newborn | Anticonvulsants | Genetic aspects | Seizures (Medicine) | Invisibility | EEG
Journal Article
Nature Communications, ISSN 2041-1723, 06/2014, Volume 5, Issue 1, p. 4011
Coffin-Siris syndrome (CSS) is a congenital disorder characterized by growth deficiency, intellectual disability, microcephaly, characteristic facial features...
EXPRESSION PATTERNS | PROGENITORS | COMPLEX | CHROMATIN | STABILITY | MULTIDISCIPLINARY SCIENCES | COMPONENTS | SUGGESTS | SOXC Transcription Factors - genetics | Face - abnormalities | Humans | Micrognathism - genetics | Child, Preschool | Zebrafish | Neck - abnormalities | Gene Knockdown Techniques | Intellectual Disability - genetics | Animals | Hand Deformities, Congenital - genetics | Adolescent | Female | SOX Transcription Factors - genetics | Mice | Mutation | Zebrafish Proteins - genetics | Abnormalities, Multiple - genetics | Cohort Studies
EXPRESSION PATTERNS | PROGENITORS | COMPLEX | CHROMATIN | STABILITY | MULTIDISCIPLINARY SCIENCES | COMPONENTS | SUGGESTS | SOXC Transcription Factors - genetics | Face - abnormalities | Humans | Micrognathism - genetics | Child, Preschool | Zebrafish | Neck - abnormalities | Gene Knockdown Techniques | Intellectual Disability - genetics | Animals | Hand Deformities, Congenital - genetics | Adolescent | Female | SOX Transcription Factors - genetics | Mice | Mutation | Zebrafish Proteins - genetics | Abnormalities, Multiple - genetics | Cohort Studies
Journal Article
Nature Genetics, ISSN 1061-4036, 04/2013, Volume 45, Issue 4, pp. 445 - 449
Static encephalopathy of childhood with neurodegeneration in adulthood (SENDA) is a recently established subtype of neurodegeneration with brain iron...
PROTEIN FAMILY | ATG PROTEINS | BRAIN IRON ACCUMULATION | DISTINCT | DISEASE | GENETICS & HEREDITY | PROPPINS | MICE | MECHANISMS | MITOPHAGY | BINDING-SITES | Spasms, Infantile - etiology | Neurodegenerative Diseases - etiology | Humans | Mutation - genetics | Autophagy | Iron - metabolism | Carrier Proteins - genetics | Magnetic Resonance Imaging | Exome - genetics | Phenotype | Lennox Gastaut Syndrome | Adult | Female | High-Throughput Nucleotide Sequencing | Intellectual Disability - etiology | Child | Autophagy (Cytology) | Nervous system | Genetic aspects | Degeneration | Encephalopathy | Patient outcomes | Proteins | Brain research | Neurodegeneration | Science | Mutation | Grants | Mammals
PROTEIN FAMILY | ATG PROTEINS | BRAIN IRON ACCUMULATION | DISTINCT | DISEASE | GENETICS & HEREDITY | PROPPINS | MICE | MECHANISMS | MITOPHAGY | BINDING-SITES | Spasms, Infantile - etiology | Neurodegenerative Diseases - etiology | Humans | Mutation - genetics | Autophagy | Iron - metabolism | Carrier Proteins - genetics | Magnetic Resonance Imaging | Exome - genetics | Phenotype | Lennox Gastaut Syndrome | Adult | Female | High-Throughput Nucleotide Sequencing | Intellectual Disability - etiology | Child | Autophagy (Cytology) | Nervous system | Genetic aspects | Degeneration | Encephalopathy | Patient outcomes | Proteins | Brain research | Neurodegeneration | Science | Mutation | Grants | Mammals
Journal Article
Internal Medicine, ISSN 0918-2918, 2017, Volume 56, Issue 6, pp. 605 - 613
Objective Dipeptidyl peptidase-4 (DPP-4) inhibitors are the most frequently prescribed oral hypoglycemic agents in Japan. Although a relationship between the...
dipeptidyl peptidase-4 inhibitor | obesity | sitagliptin | Dipeptidyl peptidase-4 inhibitor | Obesity | Sitagliptin | METFORMIN | MEDICINE, GENERAL & INTERNAL | DIPEPTIDYL PEPTIDASE-4 INHIBITORS | MONOTHERAPY | SAFETY | TOLERANCE | INSULIN SENSITIVITY | BETA-CELL FUNCTION | Body Mass Index | Hypoglycemic Agents - therapeutic use | Prospective Studies | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Japan | Middle Aged | Glycated Hemoglobin A - drug effects | Male | Diabetes Mellitus, Type 2 - epidemiology | Blood Glucose - drug effects | Obesity - epidemiology | Sitagliptin Phosphate - therapeutic use | Female | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Peptidase | Effectiveness | Diabetes mellitus | Homeostasis | Regression analysis | Glucose | Metabolism | Glucose metabolism | Body mass index | Inhibitors | Body mass | Body size | Hemoglobin | Hypoglycemic agents | Diabetes | Diabetes mellitus (non-insulin dependent) | Original
dipeptidyl peptidase-4 inhibitor | obesity | sitagliptin | Dipeptidyl peptidase-4 inhibitor | Obesity | Sitagliptin | METFORMIN | MEDICINE, GENERAL & INTERNAL | DIPEPTIDYL PEPTIDASE-4 INHIBITORS | MONOTHERAPY | SAFETY | TOLERANCE | INSULIN SENSITIVITY | BETA-CELL FUNCTION | Body Mass Index | Hypoglycemic Agents - therapeutic use | Prospective Studies | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Japan | Middle Aged | Glycated Hemoglobin A - drug effects | Male | Diabetes Mellitus, Type 2 - epidemiology | Blood Glucose - drug effects | Obesity - epidemiology | Sitagliptin Phosphate - therapeutic use | Female | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Peptidase | Effectiveness | Diabetes mellitus | Homeostasis | Regression analysis | Glucose | Metabolism | Glucose metabolism | Body mass index | Inhibitors | Body mass | Body size | Hemoglobin | Hypoglycemic agents | Diabetes | Diabetes mellitus (non-insulin dependent) | Original
Journal Article
Journal of Human Genetics, ISSN 1434-5161, 02/2015, Volume 60, Issue 2, pp. 97 - 101
Aminoacylation is the process of attaching amino acids to their cognate tRNA, and thus is essential for the translation of mRNA into protein. This direct...
LEUKOENCEPHALOPATHY | BRAIN-STEM | HUMAN-DISEASE | CAUSE HYPOMYELINATION | GENETICS & HEREDITY | SPINAL-CORD INVOLVEMENT | Amino Acyl-tRNA Synthetases - genetics | Brain Diseases - diagnosis | Humans | Brain Diseases - genetics | Family Health | Male | Electroencephalography | Epilepsy - diagnosis | Magnetic Resonance Imaging | Exome - genetics | DNA Mutational Analysis | Adolescent | Age of Onset | Epilepsy - genetics | Mutation | Child | Siblings
LEUKOENCEPHALOPATHY | BRAIN-STEM | HUMAN-DISEASE | CAUSE HYPOMYELINATION | GENETICS & HEREDITY | SPINAL-CORD INVOLVEMENT | Amino Acyl-tRNA Synthetases - genetics | Brain Diseases - diagnosis | Humans | Brain Diseases - genetics | Family Health | Male | Electroencephalography | Epilepsy - diagnosis | Magnetic Resonance Imaging | Exome - genetics | DNA Mutational Analysis | Adolescent | Age of Onset | Epilepsy - genetics | Mutation | Child | Siblings
Journal Article
Epilepsia, ISSN 0013-9580, 04/2016, Volume 57, Issue 4, pp. 566 - 573
Summary Objective GABRA1 mutations have been identified in patients with familial juvenile myoclonic epilepsy, sporadic childhood absence epilepsy, and...
Infantile epilepsy | GABRA1 | Early onset epileptic encephalopathy | GABAA receptor | De novo mutation | GABA | receptor | SUSCEPTIBILITY | GAMMA-2-SUBUNIT | GAMMA-2 SUBUNIT | CLINICAL NEUROLOGY | CHILDHOOD ABSENCE EPILEPSY | ENCEPHALOPATHY | RECEPTOR SUBUNIT MUTATIONS | FEBRILE SEIZURES PLUS | GABA(A) receptor | GENES | GABA(A) RECEPTORS | GENERALIZED EPILEPSY | Amino Acid Sequence | Spasms, Infantile - physiopathology | Humans | Child, Preschool | Molecular Sequence Data | Infant | Male | Electroencephalography | Spasms, Infantile - genetics | Mutation, Missense - genetics | Receptors, GABA-A - genetics | Female | Spasms, Infantile - diagnosis | Child | Genetic aspects | Epilepsy | Analysis | Convulsions & seizures | Mutation | Patients
Infantile epilepsy | GABRA1 | Early onset epileptic encephalopathy | GABAA receptor | De novo mutation | GABA | receptor | SUSCEPTIBILITY | GAMMA-2-SUBUNIT | GAMMA-2 SUBUNIT | CLINICAL NEUROLOGY | CHILDHOOD ABSENCE EPILEPSY | ENCEPHALOPATHY | RECEPTOR SUBUNIT MUTATIONS | FEBRILE SEIZURES PLUS | GABA(A) receptor | GENES | GABA(A) RECEPTORS | GENERALIZED EPILEPSY | Amino Acid Sequence | Spasms, Infantile - physiopathology | Humans | Child, Preschool | Molecular Sequence Data | Infant | Male | Electroencephalography | Spasms, Infantile - genetics | Mutation, Missense - genetics | Receptors, GABA-A - genetics | Female | Spasms, Infantile - diagnosis | Child | Genetic aspects | Epilepsy | Analysis | Convulsions & seizures | Mutation | Patients
Journal Article
Human Mutation, ISSN 1059-7794, 12/2013, Volume 34, Issue 12, pp. 1708 - 1714
ABSTRACT Early‐onset epileptic encephalopathies (EOEE) are severe neurological disorders characterized by frequent seizures accompanied by developmental...
SLC35A2 | early‐onset epileptic encephalopathy | congenital disorders of glycosylation | Early-onset epileptic encephalopathy | Congenital disorders of glycosylation | MENTAL-RETARDATION | SUPPRESSION-BURST PATTERN | CUTIS LAXA | GDP-FUCOSE TRANSPORTER | MYOCLONIC EPILEPSY | GENE | GENETICS & HEREDITY | CONGENITAL DISORDERS | early-onset epileptic encephalopathy | SEQUENCING DATA | GLYCOSYLATION DISORDERS | OHTAHARA-SYNDROME | RNA Isoforms | Humans | Infant | Electroencephalography | Spasms, Infantile - genetics | Exome | DNA Mutational Analysis | Facies | Female | Spasms, Infantile - diagnosis | Child | Gene Order | Infant, Newborn | Monosaccharide Transport Proteins - genetics | Cell Line | Gene Expression | Brain - physiopathology | Protein Transport | Magnetic Resonance Imaging | Phenotype | Animals | Age of Onset | Brain - pathology | High-Throughput Nucleotide Sequencing | Mice | Monosaccharide Transport Proteins - chemistry | Mutation | Galactose | Genetic aspects
SLC35A2 | early‐onset epileptic encephalopathy | congenital disorders of glycosylation | Early-onset epileptic encephalopathy | Congenital disorders of glycosylation | MENTAL-RETARDATION | SUPPRESSION-BURST PATTERN | CUTIS LAXA | GDP-FUCOSE TRANSPORTER | MYOCLONIC EPILEPSY | GENE | GENETICS & HEREDITY | CONGENITAL DISORDERS | early-onset epileptic encephalopathy | SEQUENCING DATA | GLYCOSYLATION DISORDERS | OHTAHARA-SYNDROME | RNA Isoforms | Humans | Infant | Electroencephalography | Spasms, Infantile - genetics | Exome | DNA Mutational Analysis | Facies | Female | Spasms, Infantile - diagnosis | Child | Gene Order | Infant, Newborn | Monosaccharide Transport Proteins - genetics | Cell Line | Gene Expression | Brain - physiopathology | Protein Transport | Magnetic Resonance Imaging | Phenotype | Animals | Age of Onset | Brain - pathology | High-Throughput Nucleotide Sequencing | Mice | Monosaccharide Transport Proteins - chemistry | Mutation | Galactose | Genetic aspects
Journal Article
Epilepsia, ISSN 0013-9580, 09/2015, Volume 56, Issue 9, pp. e121 - e128
Summary KCNT1 mutations have been found in epilepsy of infancy with migrating focal seizures (EIMFS; also known as migrating partial seizures in infancy),...
Early onset epileptic encephalopathies | Epilepsy of infancy with migrating focal seizures | KCNT1 | De novo mutation | SLACK | MIGRATING PARTIAL SEIZURES | GENES | INFANCY | GAIN | CLINICAL NEUROLOGY | Magnetic Resonance Imaging | DNA Mutational Analysis | Humans | Brain - pathology | Child, Preschool | Infant | Electroencephalography | Spasms, Infantile - genetics | Mutation - genetics | Child | Nerve Tissue Proteins - genetics | Potassium Channels - genetics | Genetic research | Genetic aspects | Seizures (Medicine) | Epilepsy
Early onset epileptic encephalopathies | Epilepsy of infancy with migrating focal seizures | KCNT1 | De novo mutation | SLACK | MIGRATING PARTIAL SEIZURES | GENES | INFANCY | GAIN | CLINICAL NEUROLOGY | Magnetic Resonance Imaging | DNA Mutational Analysis | Humans | Brain - pathology | Child, Preschool | Infant | Electroencephalography | Spasms, Infantile - genetics | Mutation - genetics | Child | Nerve Tissue Proteins - genetics | Potassium Channels - genetics | Genetic research | Genetic aspects | Seizures (Medicine) | Epilepsy
Journal Article
Epilepsia, ISSN 0013-9580, 06/2015, Volume 56, Issue 6, pp. 841 - 848
Summary Objective Recently, de novo mutations in GRIN1 have been identified in patients with nonsyndromic intellectual disability and epileptic encephalopathy....
Seizure | Neurotransmitter disorders | Encephalopathy | Movement disorders | GRIN1 | NMDA RECEPTOR | AUTISM | D-ASPARTATE RECEPTORS | MONOAMINE NEUROTRANSMITTER DISORDERS | SYNAPTIC PLASTICITY | CHILDHOOD | CLINICAL NEUROLOGY | DE-NOVO MUTATIONS | ION-CHANNEL | DOPAMINE D1 RECEPTOR | MICE | Genetic Predisposition to Disease - genetics | Hyperkinesis - genetics | Hyperkinesis - complications | Humans | Brain Diseases - genetics | Child, Preschool | Male | Electroencephalography | Nerve Tissue Proteins - genetics | Mutation, Missense - genetics | Epilepsy - complications | Receptors, N-Methyl-D-Aspartate - genetics | Stereotypic Movement Disorder - complications | Magnetic Resonance Imaging | DNA Mutational Analysis | Brain Diseases - complications | Adolescent | Stereotypic Movement Disorder - genetics | Epilepsy - genetics | Female | Child | Methyl aspartate | Gene mutations | Analysis | Epilepsy | Genetic aspects | Seizures (Medicine)
Seizure | Neurotransmitter disorders | Encephalopathy | Movement disorders | GRIN1 | NMDA RECEPTOR | AUTISM | D-ASPARTATE RECEPTORS | MONOAMINE NEUROTRANSMITTER DISORDERS | SYNAPTIC PLASTICITY | CHILDHOOD | CLINICAL NEUROLOGY | DE-NOVO MUTATIONS | ION-CHANNEL | DOPAMINE D1 RECEPTOR | MICE | Genetic Predisposition to Disease - genetics | Hyperkinesis - genetics | Hyperkinesis - complications | Humans | Brain Diseases - genetics | Child, Preschool | Male | Electroencephalography | Nerve Tissue Proteins - genetics | Mutation, Missense - genetics | Epilepsy - complications | Receptors, N-Methyl-D-Aspartate - genetics | Stereotypic Movement Disorder - complications | Magnetic Resonance Imaging | DNA Mutational Analysis | Brain Diseases - complications | Adolescent | Stereotypic Movement Disorder - genetics | Epilepsy - genetics | Female | Child | Methyl aspartate | Gene mutations | Analysis | Epilepsy | Genetic aspects | Seizures (Medicine)
Journal Article
Diabetology International, ISSN 2190-1678, 7/2018, Volume 9, Issue 3, pp. 179 - 188
We developed a novel estimation method for hemoglobin A1c (HbA1c) in type 2 diabetes (T2D) patients with end-stage renal disease (ESRD). This method is based...
Type 2 diabetes | End-stage renal disease | Glycated albumin | Medicine & Public Health | Hemoglobin A1c | Metabolic Diseases | Diabetes | Endocrinology
Type 2 diabetes | End-stage renal disease | Glycated albumin | Medicine & Public Health | Hemoglobin A1c | Metabolic Diseases | Diabetes | Endocrinology
Journal Article
Epilepsia, ISSN 0013-9580, 02/2014, Volume 55, Issue 2, pp. e13 - e17
Summary Aberrations in the glycosylphosphatidylinositol (GPI)–anchor biosynthesis pathway constitute a subclass of congenital disorders of glycosylation, and...
Epileptic encephalopathy | Glycosylphosphatidylinositol anchors | Congenital disorders of glycosylation | PIGO | DE-NOVO MUTATIONS | PGAP2 | ANCHOR-SYNTHESIS PATHWAY | CAUSE HYPERPHOSPHATASIA | CLINICAL NEUROLOGY | Developmental Disabilities - blood | Humans | Infant | Male | Developmental Disabilities - genetics | Intellectual Disability - genetics | Intellectual Disability - blood | Phosphorus Metabolism Disorders - genetics | Fatal Outcome | Epilepsy - genetics | Female | Hemoglobinuria, Paroxysmal - blood | Hemoglobinuria, Paroxysmal - diagnosis | Membrane Proteins - blood | Child | Developmental Disabilities - diagnosis | Abnormalities, Multiple - genetics | Alkaline Phosphatase - blood | Abnormalities, Multiple - blood | Severity of Illness Index | Glycosylphosphatidylinositols - blood | Phosphorus Metabolism Disorders - diagnosis | Membrane Proteins - genetics | Mutation - genetics | Phosphorus Metabolism Disorders - blood | Epilepsy - diagnosis | Pedigree | Abnormalities, Multiple - diagnosis | Intellectual Disability - diagnosis | Glycosylphosphatidylinositols - deficiency | Epilepsy - blood | Proteins | Fc receptors | Genetic disorders | Phosphatases | Epilepsy | Physiological aspects | Genetic aspects | Mental illness | Mutation
Epileptic encephalopathy | Glycosylphosphatidylinositol anchors | Congenital disorders of glycosylation | PIGO | DE-NOVO MUTATIONS | PGAP2 | ANCHOR-SYNTHESIS PATHWAY | CAUSE HYPERPHOSPHATASIA | CLINICAL NEUROLOGY | Developmental Disabilities - blood | Humans | Infant | Male | Developmental Disabilities - genetics | Intellectual Disability - genetics | Intellectual Disability - blood | Phosphorus Metabolism Disorders - genetics | Fatal Outcome | Epilepsy - genetics | Female | Hemoglobinuria, Paroxysmal - blood | Hemoglobinuria, Paroxysmal - diagnosis | Membrane Proteins - blood | Child | Developmental Disabilities - diagnosis | Abnormalities, Multiple - genetics | Alkaline Phosphatase - blood | Abnormalities, Multiple - blood | Severity of Illness Index | Glycosylphosphatidylinositols - blood | Phosphorus Metabolism Disorders - diagnosis | Membrane Proteins - genetics | Mutation - genetics | Phosphorus Metabolism Disorders - blood | Epilepsy - diagnosis | Pedigree | Abnormalities, Multiple - diagnosis | Intellectual Disability - diagnosis | Glycosylphosphatidylinositols - deficiency | Epilepsy - blood | Proteins | Fc receptors | Genetic disorders | Phosphatases | Epilepsy | Physiological aspects | Genetic aspects | Mental illness | Mutation
Journal Article
Epilepsia, ISSN 0013-9580, 07/2013, Volume 54, Issue 7, pp. 1262 - 1269
Summary Purpose Early onset epileptic encephalopathies (EOEEs) are heterogeneous epileptic disorders caused by various abnormalities in causative genes...
Copy number variation | Target capture | Mutation | Genetic testing | Sequencing | WEST SYNDROME | CDKL5 | HYPOMYELINATION | VARIANTS | PLATFORMS | STXBP1 MUTATIONS | CLINICAL NEUROLOGY | SEIZURES | GENE | OHTAHARA SYNDROME | MOSAICISM | Genetic Testing | Munc18 Proteins - genetics | Humans | NAV1.1 Voltage-Gated Sodium Channel - genetics | NAV1.2 Voltage-Gated Sodium Channel - genetics | Male | DNA Copy Number Variations - genetics | Electroencephalography | Spasms, Infantile - genetics | Mutation - genetics | Carrier Proteins - genetics | Microarray Analysis | Female | Microfilament Proteins - genetics | Sequence Analysis, DNA - methods | Gene mutations | Analysis | Genes | Genomics | Genetic research | Antisense RNA | Genetic aspects
Copy number variation | Target capture | Mutation | Genetic testing | Sequencing | WEST SYNDROME | CDKL5 | HYPOMYELINATION | VARIANTS | PLATFORMS | STXBP1 MUTATIONS | CLINICAL NEUROLOGY | SEIZURES | GENE | OHTAHARA SYNDROME | MOSAICISM | Genetic Testing | Munc18 Proteins - genetics | Humans | NAV1.1 Voltage-Gated Sodium Channel - genetics | NAV1.2 Voltage-Gated Sodium Channel - genetics | Male | DNA Copy Number Variations - genetics | Electroencephalography | Spasms, Infantile - genetics | Mutation - genetics | Carrier Proteins - genetics | Microarray Analysis | Female | Microfilament Proteins - genetics | Sequence Analysis, DNA - methods | Gene mutations | Analysis | Genes | Genomics | Genetic research | Antisense RNA | Genetic aspects
Journal Article
The American Journal of Human Genetics, ISSN 0002-9297, 09/2013, Volume 93, Issue 3, pp. 496 - 505
Heterotrimeric G proteins, composed of α, β, and γ subunits, can transduce a variety of signals from seven-transmembrane-type receptors to intracellular...
GTP-Binding Protein alpha Subunits, Gi-Go - genetics | Calcium - metabolism | Humans | Child, Preschool | Molecular Sequence Data | Infant | Electroencephalography | Epilepsy - physiopathology | GTP-Binding Protein alpha Subunits, Gi-Go - chemistry | Epilepsy - genetics | Female | Child | Amino Acid Sequence | Genetic Predisposition to Disease | Mutant Proteins - genetics | Models, Molecular | Mutant Proteins - metabolism | Signal Transduction - genetics | Mutation - genetics | Sequence Analysis, DNA | Protein Transport | Magnetic Resonance Imaging | Exome - genetics | Phenotype | Animals | Mutant Proteins - chemistry | Amino Acid Substitution - genetics | Mice | Epilepsy - pathology
GTP-Binding Protein alpha Subunits, Gi-Go - genetics | Calcium - metabolism | Humans | Child, Preschool | Molecular Sequence Data | Infant | Electroencephalography | Epilepsy - physiopathology | GTP-Binding Protein alpha Subunits, Gi-Go - chemistry | Epilepsy - genetics | Female | Child | Amino Acid Sequence | Genetic Predisposition to Disease | Mutant Proteins - genetics | Models, Molecular | Mutant Proteins - metabolism | Signal Transduction - genetics | Mutation - genetics | Sequence Analysis, DNA | Protein Transport | Magnetic Resonance Imaging | Exome - genetics | Phenotype | Animals | Mutant Proteins - chemistry | Amino Acid Substitution - genetics | Mice | Epilepsy - pathology
Journal Article
Diabetes, ISSN 0012-1797, 04/2012, Volume 61, Issue 4, pp. 897 - 907
Inflammatory process is involved in the pathogenesis of diabetic nephropathy. In this article, we show that cholecystokinin (CCK) is expressed in the kidney...
CCK-A RECEPTOR | INTERCELLULAR-ADHESION MOLECULE-1 | RAT | ENDOCRINOLOGY & METABOLISM | PULMONARY INTERSTITIAL MACROPHAGES | ANGIOTENSIN-II | MICE | NF-KAPPA-B | EXPRESSION | NEPHROPATHY | MONOCYTE MIGRATION | Tumor Necrosis Factor-alpha - metabolism | Tumor Necrosis Factor-alpha - genetics | Sincalide - pharmacology | Receptor, Cholecystokinin B - metabolism | Male | NF-kappa B - metabolism | Chemokines, CC | Gene Expression Profiling | Cholecystokinin - metabolism | Inflammation - metabolism | Kidney - metabolism | Receptors, Cholecystokinin - genetics | Macrophages - physiology | Sincalide - analogs & derivatives | Diabetes Mellitus - metabolism | Gene Expression Regulation - physiology | Chemotaxis - drug effects | Receptor, Cholecystokinin B - genetics | Receptors, Cholecystokinin - metabolism | Mice, Knockout | Intercellular Adhesion Molecule-1 - metabolism | Animals | Cholecystokinin - genetics | NF-kappa B - genetics | Intercellular Adhesion Molecule-1 - genetics | Mice | Physiological aspects | Cholecystokinin | Research | Diabetic nephropathies | Complications
CCK-A RECEPTOR | INTERCELLULAR-ADHESION MOLECULE-1 | RAT | ENDOCRINOLOGY & METABOLISM | PULMONARY INTERSTITIAL MACROPHAGES | ANGIOTENSIN-II | MICE | NF-KAPPA-B | EXPRESSION | NEPHROPATHY | MONOCYTE MIGRATION | Tumor Necrosis Factor-alpha - metabolism | Tumor Necrosis Factor-alpha - genetics | Sincalide - pharmacology | Receptor, Cholecystokinin B - metabolism | Male | NF-kappa B - metabolism | Chemokines, CC | Gene Expression Profiling | Cholecystokinin - metabolism | Inflammation - metabolism | Kidney - metabolism | Receptors, Cholecystokinin - genetics | Macrophages - physiology | Sincalide - analogs & derivatives | Diabetes Mellitus - metabolism | Gene Expression Regulation - physiology | Chemotaxis - drug effects | Receptor, Cholecystokinin B - genetics | Receptors, Cholecystokinin - metabolism | Mice, Knockout | Intercellular Adhesion Molecule-1 - metabolism | Animals | Cholecystokinin - genetics | NF-kappa B - genetics | Intercellular Adhesion Molecule-1 - genetics | Mice | Physiological aspects | Cholecystokinin | Research | Diabetic nephropathies | Complications
Journal Article